AAAAAA

   
Results: 1-8 |
Results: 8
IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA
Authors: KLEIN SI CZEKAJ M GARDNER CJ GUERTIN KR CHENEY DL SPADA AP BOLTON SA BROWN K COLUSSI D HERAN CL MORGAN SR LEADLEY RJ DUNWIDDIE CT PERRONE MH CHU V
Citation: Si. Klein et al., IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA, Journal of medicinal chemistry, 41(4), 1998, pp. 437-450
LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) AND THROMBIN ACTIVE-SITE INHIBITOR (ARGATROBAN) COMPARED IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME
Authors: SCHUMACHER WA HERAN CL STEINBACHER TE
Citation: Wa. Schumacher et al., LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) AND THROMBIN ACTIVE-SITE INHIBITOR (ARGATROBAN) COMPARED IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME, Journal of cardiovascular pharmacology, 28(1), 1996, pp. 19-25
SENSITIVITY OF EXPERIMENTAL VENOUS AND ARTERIAL THROMBOSIS AND BLEEDING TO ANCROD-INDUCED DEFIBRINOGENATION
Authors: SCHUMACHER WA HERAN CL STEINBACHER TE
Citation: Wa. Schumacher et al., SENSITIVITY OF EXPERIMENTAL VENOUS AND ARTERIAL THROMBOSIS AND BLEEDING TO ANCROD-INDUCED DEFIBRINOGENATION, Thrombosis research, 81(2), 1996, pp. 187-194
COMPARISON OF A LOW-MOLECULAR-WEIGHT HEPARIN AND THROMBIN ACTIVE-SITEINHIBITOR IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME
Authors: SCHUMACHER WA STEINBACHER TE HERAN CL
Citation: Wa. Schumacher et al., COMPARISON OF A LOW-MOLECULAR-WEIGHT HEPARIN AND THROMBIN ACTIVE-SITEINHIBITOR IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME, Thrombosis and haemostasis, 69(6), 1993, pp. 657-657
EFFECTS OF ANTITHROMBOTIC DRUGS IN A RAT MODEL OF ASPIRIN-INSENSITIVEARTERIAL THROMBOSIS
Authors: SCHUMACHER WA STEINBACHER TE HERAN CL MEGILL JR DURHAM SK
Citation: Wa. Schumacher et al., EFFECTS OF ANTITHROMBOTIC DRUGS IN A RAT MODEL OF ASPIRIN-INSENSITIVEARTERIAL THROMBOSIS, Thrombosis and haemostasis, 69(5), 1993, pp. 509-514
COMPARISON OF A THROMBOXANE RECEPTOR ANTAGONIST AND ASPIRIN IN EXPERIMENTAL ARTERIAL THROMBOSIS
Authors: SCHUMACHER WA HERAN CL YOUSSEF S MEGILL JR MICHEL I DURHAM SK
Citation: Wa. Schumacher et al., COMPARISON OF A THROMBOXANE RECEPTOR ANTAGONIST AND ASPIRIN IN EXPERIMENTAL ARTERIAL THROMBOSIS, Haemostasis, 23(4), 1993, pp. 219-228
SUPERIOR ACTIVITY OF A THROMBOXANE RECEPTOR ANTAGONIST AS COMPARED WITH ASPIRIN IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS
Authors: SCHUMACHER WA HERAN CL STEINBACHER TE YOUSSEF S OGLETREE ML
Citation: Wa. Schumacher et al., SUPERIOR ACTIVITY OF A THROMBOXANE RECEPTOR ANTAGONIST AS COMPARED WITH ASPIRIN IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS, Journal of cardiovascular pharmacology, 22(4), 1993, pp. 526-533
COMPARISON OF THROMBIN ACTIVE-SITE AND EXOSITE INHIBITORS AND HEPARININ EXPERIMENTAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING
Authors: SCHUMACHER WA STEINBACHER TE HERAN CL SEILER SM MICHEL IM OGLETREE ML
Citation: Wa. Schumacher et al., COMPARISON OF THROMBIN ACTIVE-SITE AND EXOSITE INHIBITORS AND HEPARININ EXPERIMENTAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1237-1242
Risultati: 1-8 |